These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38795936)

  • 21. Candida auris: Clinical profile, diagnostic challenge and susceptibility pattern: Experience from a tertiary-care centre in South India.
    Ninan MM; Sahni RD; Chacko B; Balaji V; Michael JS
    J Glob Antimicrob Resist; 2020 Jun; 21():181-185. PubMed ID: 31655136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of Two Commercial Colorimetric Broth Microdilution Tests for
    Philips S; Van Hoecke F; De Laere E; Vervaeke S; De Smedt R; Boelens J; De Geyter D; Piérard D; Lagrou K
    J Fungi (Basel); 2021 May; 7(5):. PubMed ID: 34062848
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Maphanga TG; Naicker SD; Kwenda S; Muñoz JF; van Schalkwyk E; Wadula J; Nana T; Ismail A; Coetzee J; Govind C; Mtshali PS; Mpembe RS; Govender NP;
    Antimicrob Agents Chemother; 2021 Aug; 65(9):e0051721. PubMed ID: 34228535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Method-Dependent Epidemiological Cutoff Values for Detection of Triazole Resistance in
    Espinel-Ingroff A; Turnidge J; Alastruey-Izquierdo A; Botterel F; Canton E; Castro C; Chen YC; Chen Y; Chryssanthou E; Dannaoui E; Garcia-Effron G; Gonzalez GM; Govender NP; Guinea J; Kidd S; Lackner M; Lass-Flörl C; Linares-Sicilia MJ; López-Soria L; Magobo R; Pelaez T; Quindós G; Rodriguez-Iglesia MA; Ruiz MA; Sánchez-Reus F; Sanguinetti M; Shields R; Szweda P; Tortorano A; Wengenack NL; Bramati S; Cavanna C; DeLuca C; Gelmi M; Grancini A; Lombardi G; Meletiadis J; Negri CE; Passera M; Peman J; Prigitano A; Sala E; Tejada M
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30323038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical evaluation of the Sensititre YeastOne colorimetric antifungal panel for antifungal susceptibility testing of the echinocandins anidulafungin, caspofungin, and micafungin.
    Pfaller MA; Chaturvedi V; Diekema DJ; Ghannoum MA; Holliday NM; Killian SB; Knapp CC; Messer SA; Miskov A; Ramani R
    J Clin Microbiol; 2008 Jul; 46(7):2155-9. PubMed ID: 18463213
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Zhang W; Zhan M; Wang N; Fan J; Han X; Li C; Liu J; Li J; Hou Y; Wang X; Zhang Z
    J Med Microbiol; 2023 Mar; 72(3):. PubMed ID: 36920840
    [No Abstract]   [Full Text] [Related]  

  • 27. Accuracy of Sensititre YeastOne echinocandins epidemiological cut-off values for identification of FKS mutant Candida albicans and Candida glabrata: a ten year national survey of the Fungal Infection Network of Switzerland (FUNGINOS).
    Kritikos A; Neofytos D; Khanna N; Schreiber PW; Boggian K; Bille J; Schrenzel J; Mühlethaler K; Zbinden R; Bruderer T; Goldenberger D; Pfyffer G; Conen A; Van Delden C; Zimmerli S; Sanglard D; Bachmann D; Marchetti O; Lamoth F;
    Clin Microbiol Infect; 2018 Nov; 24(11):1214.e1-1214.e4. PubMed ID: 29909005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increasing prevalence, molecular characterization and antifungal drug susceptibility of serial Candida auris isolates in Kuwait.
    Khan Z; Ahmad S; Al-Sweih N; Joseph L; Alfouzan W; Asadzadeh M
    PLoS One; 2018; 13(4):e0195743. PubMed ID: 29630658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Candida auris in various hospitals across Kuwait and their susceptibility and molecular basis of resistance to antifungal drugs.
    Ahmad S; Khan Z; Al-Sweih N; Alfouzan W; Joseph L
    Mycoses; 2020 Jan; 63(1):104-112. PubMed ID: 31618799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Susceptibility testing of Prototheca bovis isolates from cases of bovine mastitis using the CLSI reference broth microdilution method and the Sensititre YeastOne colorimetric panel.
    Álvarez-Pérez S; Anega B; Díaz-de-Tuesta JA; González-Martín JV; Riesgo-Martínez M; García ME; Blanco JL
    Med Mycol; 2021 Dec; 59(12):1257-1261. PubMed ID: 34643716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and Antifungal Drug Susceptibility Pattern of
    Deshkar S; Patil N; Amberkar S; Lad A; Siddiqui F; Sharan S
    J Glob Infect Dis; 2022; 14(4):131-135. PubMed ID: 36636301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antifungal susceptibility profile of invasive
    Memon S; Farooqi J; Zafar U; Naqvi SF; Zafar A; Jabeen K
    J Med Microbiol; 2021 Dec; 70(12):. PubMed ID: 34878377
    [No Abstract]   [Full Text] [Related]  

  • 33. Antifungal susceptibilities of Candida isolates causing bloodstream infections at a medical center in Taiwan, 2009-2010.
    Huang YT; Liu CY; Liao CH; Chung KP; Sheng WH; Hsueh PR
    Antimicrob Agents Chemother; 2014 Jul; 58(7):3814-9. PubMed ID: 24752274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Real-world experience with echinocandin MICs against Candida species in a multicenter study of hospitals that routinely perform susceptibility testing of bloodstream isolates.
    Eschenauer GA; Nguyen MH; Shoham S; Vazquez JA; Morris AJ; Pasculle WA; Kubin CJ; Klinker KP; Carver PL; Hanson KE; Chen S; Lam SW; Potoski BA; Clarke LG; Shields RK; Clancy CJ
    Antimicrob Agents Chemother; 2014; 58(4):1897-906. PubMed ID: 24395235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activities of nine antifungal agents against Candida auris biofilms.
    Chatzimoschou A; Giampani A; Meis JF; Roilides E
    Mycoses; 2021 Apr; 64(4):381-384. PubMed ID: 33270284
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    O'Brien B; Chaturvedi S; Chaturvedi V
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31932367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. APX001A
    Arendrup MC; Chowdhary A; Astvad KMT; Jørgensen KM
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30104264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multicenter Italian Study on "In Vitro Activities" of Isavuconazole, Voriconazole, Amphotericin B, and Caspofungin for
    Lo Cascio G; Bazaj A; Trovato L; Sanna S; Andreoni S; Blasi E; Conte M; Fazii P; Oliva E; Lepera V; Lombardi G; Farina C
    Infect Drug Resist; 2022; 15():5839-5848. PubMed ID: 36217342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of three statistical methods for establishing tentative wild-type population and epidemiological cutoff values for echinocandins, amphotericin B, flucytosine, and six Candida species as determined by the colorimetric Sensititre YeastOne method.
    Cantón E; Pemán J; Hervás D; Iñiguez C; Navarro D; Echeverría J; Martínez-Alarcón J; Fontanals D; Gomila-Sard B; Buendía B; Torroba L; Ayats J; Bratos A; Sánchez-Reus F; Fernández-Natal I;
    J Clin Microbiol; 2012 Dec; 50(12):3921-6. PubMed ID: 23015676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the Vitek 2 antifungal susceptibility system with the clinical and laboratory standards institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) Broth Microdilution Reference Methods and with the Sensititre YeastOne and Etest techniques for in vitro detection of antifungal resistance in yeast isolates.
    Cuenca-Estrella M; Gomez-Lopez A; Alastruey-Izquierdo A; Bernal-Martinez L; Cuesta I; Buitrago MJ; Rodriguez-Tudela JL
    J Clin Microbiol; 2010 May; 48(5):1782-6. PubMed ID: 20220169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.